SCHEMBL18007012

SCHEMBL18007012

CCCCC(Br)c1c(Cl)cccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP3A4 P08684 2/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DRD3 P35462 2/20 0.34
DRD2 P14416 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
OPRM1 P35372 3/20 0.33
OPRD1 P41143 3/20 0.33
OPRK1 P41145 3/20 0.33
OPRL1 P41146 3/20 0.33
HPGD P15428 1/20 0.33
KCNH2 Q12809 1/20 0.33
NR4A2 P43354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428343 0.80 MEN1 (0.40) MEN1KMT2ACYP3A4TP53CYP1A2
SCHEMBL6685354 0.79 NISCH (0.40) MEN1KMT2ACYP3A4TSHRCYP2C19
SCHEMBL15786471 0.78 MEN1 (0.39) MEN1KMT2ACYP3A4TP53CYP1A2
SCHEMBL15698546 0.78 CFD (0.47) MEN1KMT2ACYP3A4CYP1A2DRD3
SCHEMBL18006937 0.77 SMN1; SMN2 (0.34) MEN1KMT2ACYP3A4DRD3DRD2
SCHEMBL18241990 0.76 TAS1R3 (0.39) MEN1KMT2ACYP3A4TP53CYP1A2
SCHEMBL5487851 0.76 FFAR1 (0.37) CYP3A4TDP1KCNH2LMNACA2
SCHEMBL252530 0.74 MEN1 (0.39) MEN1KMT2ACYP3A4TP53CYP1A2
SCHEMBL253314 0.74 MEN1 (0.39) MEN1KMT2ACYP3A4TP53CYP1A2
SCHEMBL252988 0.74 MEN1 (0.39) MEN1KMT2ACYP3A4TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016132134-A1 THIAZOLE DERIVATIVES FOR THE TREATMENT OF ANIMAL TRYPANOSOMIASIS UNIVERSITY OF DUNDEE (GB) 2016-08-25 WO disclosed